Premium
P4‐144: A survey of knowledge, beliefs, and attitudes regarding genetic and amyloid PET status disclosure
Author(s) -
Ott Brian R.,
Pelosi Marissa A.,
Tremont Geoffrey,
Snyder Peter J.
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.1850
Subject(s) - feeling , viewpoints , test (biology) , apolipoprotein e , psychology , amyloid (mycology) , clinical psychology , association (psychology) , medicine , gerontology , family medicine , social psychology , pathology , disease , psychotherapist , paleontology , art , visual arts , biology
Figure. Longitudinal trends in Alzheimer disease severity in the ADNIj (left panel) and BIOCARD (right panel). This figure shows a random sample of longitudinal trajectories for select ADNI (left panel) and BIOCARD (right panel) subgroups. Persons who begin the study in the normal group and do not convert over 48M follow-up are shown with solid blue lines without markers (dots). The average trajectory for this group is shown with a heavy blue dashed line. MCI cases who do not convert to dementia are shown with solid green lines and the average trend line for these cases is shown by the heavy dashed green line. Persons who begin with clinical AD are shown in solid red lines. The trend line for this group is shown with a heavy dashed red line. Persons who convert (either from normal to mild cognitive impairment (MCI) or AD or form MCI to AD are drawn with black lines, and colored dots indicate their current (at time of assessment) clinical stage as indicated in the key. The average trajectory for this group is shown with a solid black line. Values plotted are best unbiased linear predictors based on a linear mixed effect regression model of predicted AD severity score score.